REPL Financials

Income Statement
MetricQ2 2027Q1 2027Q4 2026Q3 2026Q2 2026
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
56.3M
-17.5%
68.2M
-6.9%
73.3M
+2.0%
71.9M
-14.7%
84.3M
R&D
34.4M
-30.3%
49.3M
-5.8%
52.3M
-1.5%
53.1M
-8.2%
57.9M
SG&A
21.9M
+15.5%
19.0M
-9.7%
21.0M
+12.2%
18.7M
-29.1%
26.4M
Operating Income
-56281000
+17.5%
-68247000
+6.9%
-73338000
-2.0%
-71868000
+14.7%
-84291000
EBITDA
-55508000
+17.5%
-67310000
+7.2%
-72569000
-4.7%
-69305000
+16.9%
-83449000
Net Income
-57121000
+18.1%
-69766000
+4.7%
-73217000
-3.2%
-70930000
+14.6%
-83100000
EPS (Basic)
$-0.54
+25.0%
$-0.72
+6.5%
$-0.77
+0.0%
$-0.77
+14.4%
$-0.90
EPS (Diluted)
$-0.54
+25.0%
$-0.72
+6.5%
$-0.77
+0.0%
$-0.77
+14.4%
$-0.90
Shares (Diluted)
105.2M
+8.6%
96.9M
+1.3%
95.6M
+3.7%
92.2M
+0.3%
91.9M
Replimune (REPL) — Financials